WEREWOLF THERAPEUTICS

Werewolf Therapeutics to Participate in May Investor Conferences

01 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Publishes Preclinical Data on mWTX-330, an IL-12 INDUKINE™ Molecule, in Cancer Immunology Research

19 4月 2023 09:00:15 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

23 3月 2023 06:00:00 条件 Nasdaq GlobeNewswire

UPDATE -- Werewolf Therapeutics Announces Upcoming Presentations at AACR Annual Meeting 2023

16 3月 2023 06:30:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2023

15 3月 2023 06:30:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1 Study of WTX-330

24 2月 2023 06:30:03 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at the SVB Securities Global Biopharma Conference

07 2月 2023 06:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Presents Preclinical Data on mWTX-330, a Surrogate IL-12 INDUKINE™ Molecule, at the Society for Immunotherapy of Cancer Annual Meeting

10 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

10 11月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present Preclinical Data at Society for Immunotherapy of Cancer Annual Meeting and Participate in Upcoming Investor Conferences

07 11月 2022 15:05:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference

07 9月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Initiation of Patient Dosing in Phase 1/1b Clinical Trial of WTX-124 for the Treatment of Patients with Selected Solid Tumors

01 9月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Highlights

11 8月 2022 06:00:03 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Participate in the 2022 Wedbush PacGrow Healthcare Virtual Conference

03 8月 2022 06:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference

06 6月 2022 15:51:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights

10 5月 2022 06:00:02 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Presents Promising Preclinical Data on its Two Lead INDUKINE™ Molecules at AACR 2022 Annual Meeting

08 4月 2022 12:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Provides Business Highlights

24 3月 2022 06:00:01 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment

16 3月 2022 07:00:00 条件 Nasdaq GlobeNewswire

Werewolf Therapeutics Announces Upcoming Presentations at AACR 2022 Annual Meeting

15 3月 2022 07:00:01 条件 Nasdaq GlobeNewswire